Skip to content
healthcare.dev

Glipizide

NDC 82868-025, Glipizide, tablet, extended release, from Northwind Health Company, LLC.

Product NDC
82868-025
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206928
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82868-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLIPIZIDE5 mg/1

Pharmacologic classes

Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]

Package NDCNDC-11Package
82868-025-308286800253030 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-025-30)
82868-025-908286800259090 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-025-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0a1e1152-ade7-2092-e063-6394a90a99e7

Use it

Look up 82868-025 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82868-025 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82868-025. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.